The Russian government has significantly tightened responsibility for the sale and production of counterfeit drugs, through the introduction of amendments relating to activities in the national Criminal Code.
It is planned that the maximum penalty for the production of counterfeit drugs will involve the imposition of a fine in the amount of 5 million roubles ($150,000), and in some cases up to 12 years’ imprisonment.
According to Alexander Prokopiev, a member of the Russian Parliament (State Duma) and one of the initiators of the new amendments, the current Russian legislation in the field of pharmaceuticals, so far, has been ineffective to combat counterfeiters and has not always allowed to prosecute suspects and was associated with complex proof procedure.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze